Morgan Stanley GYRE THERAPEUTICS INC Transaction History

Morgan Stanley

  • $1.36 Trillion
  • Q1 2025
Number of Shares
14,030
Previous 15,241 7.95%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025
SELL
N/A
-1,211 Reduced 7.95%
14,030 $0
Q4 2024

Feb 14, 2025
SELL
N/A
-2,981 Reduced 16.36%
15,241 $0
Q3 2024

May 14, 2025
BUY
N/A
10,949 Added 150.54%
18,222 $0
Q3 2024

Nov 14, 2024
BUY
N/A
10,949 Added 150.54%
18,222 $0
Q2 2024

May 14, 2025
SELL
N/A
-7,968 Reduced 52.28%
7,273 $0
Q2 2024

Oct 17, 2024
BUY
N/A
1,567 Added 27.46%
7,273 $0
Q2 2024

Aug 14, 2024
BUY
N/A
1,567 Added 27.46%
7,273 $0
Q1 2024

Oct 17, 2024
SELL
N/A
-1,567 Reduced 21.55%
5,706 $0
Q1 2024

Aug 16, 2024
SELL
N/A
-1,567 Reduced 21.55%
5,706 $0
Q1 2024

May 15, 2024
BUY
N/A
5,706 New
5,706 $0
Track This Portfolio

Track Morgan Stanley Portfolio

Follow Morgan Stanley and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email